David Stanton is a patent agent at Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice.
Prior to joining the firm, David earned a Ph.D. in biomedical sciences from West Virginia University, where his doctoral research focused on the development of transcriptional and metabolic dysfunction within peripheral tissues induced by breast cancer growth. During this time, he developed technical expertise in cell and molecular biology, biochemistry, physiology, cancer cell biology, and related fields.
David has previously worked as an intellectual property and commercialization intern at West Virginia University’s Office of Technology Transfer, where he gained experience managing the Health Sciences IP portfolio, performing prior art and patentability analyses, drafting provisional applications, and marketing technologies to potential licensees.
David Stanton is a patent agent at Wilson Sonsini Goodrich & Rosati, where he is a member of the patents and innovations practice.
Prior to joining the firm, David earned a Ph.D. in biomedical sciences from West Virginia University, where his doctoral research focused on the development of transcriptional and metabolic dysfunction within peripheral tissues induced by breast cancer growth. During this time, he developed technical expertise in cell and molecular biology, biochemistry, physiology, cancer cell biology, and related fields.
David has previously worked as an intellectual property and commercialization intern at West Virginia University’s Office of Technology Transfer, where he gained experience managing the Health Sciences IP portfolio, performing prior art and patentability analyses, drafting provisional applications, and marketing technologies to potential licensees.